BIOMAT Database Logo BIOMAT Database Logo

[Methylprednisolone pulse therapy in the early phases of lupus nephritis]. 1996

I Mitić, and D Fele, and P Lenert, and S Curić, and S Vodopivec, and D Bozić, and V Sakac, and M Djisalov, and T Ilić, and L Sebić, and T Djurdjević-Mirković, and P Tepavcević
Clinic of Nephrology and Clinical Immunology, Institut of Internal Diseases, Novi Sad.

Renal involvement i.e. lupus nephritis (LN) in systemic lupus erythematosus (SLE) mainly determines course and outcome of the disease. Recognition of early manifestations of LN makes adequate therapy possible, with very good therapeutic results. We report 7 patients from a group of 150 SLE patients under our permanent control, 4 female and 3 male, mean age 21 years. All of them had signs of LN: proteinuria 7/7 haematuria 4/7 without azotaemia. Renal biopsy was performed in 6 pts, and histological finding was: class II 1 pt, class IV 3 pts and class V in 2 pts. In 4 pts tubulointerstitial changes were noted, while all showed immunofluorescent deposits of immunoglobulins and complement. Methylprednisolone "pulse" therapy (1000 mg, i.v., 3 days) followed by tapering of the steroid dose was given. Reduction of proteinuria and disappearance of haematuria were observed in all patients. During follow up, kidney function remained normal.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D008181 Lupus Nephritis Glomerulonephritis associated with autoimmune disease SYSTEMIC LUPUS ERYTHEMATOSUS. Lupus nephritis is histologically classified into 6 classes: class I - normal glomeruli, class II - pure mesangial alterations, class III - focal segmental glomerulonephritis, class IV - diffuse glomerulonephritis, class V - diffuse membranous glomerulonephritis, and class VI - advanced sclerosing glomerulonephritis (The World Health Organization classification 1982). Glomerulonephritis, Lupus,Lupus Glomerulonephritis,Nephritis, Lupus,Glomerulonephritides, Lupus,Lupus Glomerulonephritides,Lupus Nephritides,Nephritides, Lupus
D008297 Male Males
D008775 Methylprednisolone A PREDNISOLONE derivative with similar anti-inflammatory action. 6-Methylprednisolone,Medrol,Metipred,Urbason,6 Methylprednisolone
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

I Mitić, and D Fele, and P Lenert, and S Curić, and S Vodopivec, and D Bozić, and V Sakac, and M Djisalov, and T Ilić, and L Sebić, and T Djurdjević-Mirković, and P Tepavcević
Pulse methylprednisolone therapy in diffuse proliferative lupus nephritis.
July 1982, The Journal of pediatrics,
I Mitić, and D Fele, and P Lenert, and S Curić, and S Vodopivec, and D Bozić, and V Sakac, and M Djisalov, and T Ilić, and L Sebić, and T Djurdjević-Mirković, and P Tepavcević
[Indication of methylprednisolone "pulse" therapy on lupus nephritis].
September 1982, Nihon Jinzo Gakkai shi,
I Mitić, and D Fele, and P Lenert, and S Curić, and S Vodopivec, and D Bozić, and V Sakac, and M Djisalov, and T Ilić, and L Sebić, and T Djurdjević-Mirković, and P Tepavcević
Methylprednisolone pulse therapy for lupus nephritis: a followup study.
January 1984, Clinical and experimental rheumatology,
I Mitić, and D Fele, and P Lenert, and S Curić, and S Vodopivec, and D Bozić, and V Sakac, and M Djisalov, and T Ilić, and L Sebić, and T Djurdjević-Mirković, and P Tepavcević
Methylprednisolone pulse therapy in Japanese children with severe lupus nephritis.
October 2001, Pediatric nephrology (Berlin, Germany),
I Mitić, and D Fele, and P Lenert, and S Curić, and S Vodopivec, and D Bozić, and V Sakac, and M Djisalov, and T Ilić, and L Sebić, and T Djurdjević-Mirković, and P Tepavcević
Lupus nephritis: efficacy of monthly pulse therapy with intravenous methylprednisolone.
March 1989, Southern medical journal,
I Mitić, and D Fele, and P Lenert, and S Curić, and S Vodopivec, and D Bozić, and V Sakac, and M Djisalov, and T Ilić, and L Sebić, and T Djurdjević-Mirković, and P Tepavcević
Beneficial effects of methylprednisolone "pulse" therapy in diffuse proliferative lupus nephritis.
January 1976, Lancet (London, England),
I Mitić, and D Fele, and P Lenert, and S Curić, and S Vodopivec, and D Bozić, and V Sakac, and M Djisalov, and T Ilić, and L Sebić, and T Djurdjević-Mirković, and P Tepavcević
[Intravenous administration of high doses (pulse therapy) of methylprednisolone in lupus nephritis].
January 1983, Terapevticheskii arkhiv,
I Mitić, and D Fele, and P Lenert, and S Curić, and S Vodopivec, and D Bozić, and V Sakac, and M Djisalov, and T Ilić, and L Sebić, and T Djurdjević-Mirković, and P Tepavcević
Acute lupus peritonitis during treatment of lupus nephritis: successful treatment with methylprednisolone pulse therapy.
December 2000, Nephron,
I Mitić, and D Fele, and P Lenert, and S Curić, and S Vodopivec, and D Bozić, and V Sakac, and M Djisalov, and T Ilić, and L Sebić, and T Djurdjević-Mirković, and P Tepavcević
Treatment of proliferative lupus nephritis with methylprednisolone pulse therapy and oral azathioprine.
January 1995, The Netherlands journal of medicine,
I Mitić, and D Fele, and P Lenert, and S Curić, and S Vodopivec, and D Bozić, and V Sakac, and M Djisalov, and T Ilić, and L Sebić, and T Djurdjević-Mirković, and P Tepavcević
A controlled trial of pulse cyclophosphamide versus pulse methylprednisolone in severe lupus nephritis.
April 1994, Lupus,
Copied contents to your clipboard!